Therefore, taking advantage of an oncogenic Ras expression and Rb inactivation-based in vitro model of gliomagenesis, as previously reported [12], we explored whether these specific genetic alterations induce a cell phenotype compatible with glioma cell evasion from NK cell-mediated cytotoxicity. This evidence concerns the gene RB1 and central nervous system cancer.